Showing 2081-2090 of 2235 results for "".
- Modern Aesthetics® Magazine’s Exclusive First Look at the Annual AAFPRS Survey Resultshttps://modernaesthetics.com/news/modern-aesthetics-magazines-exclusive-first-look-at-annual-aafprs-survey/2472881/Facial plastic surgery procedures increased 6 percent last year compared to 2018, according to the
- FDA Sets November PDUFA Date for DaxibotulinumtoxinA from Revancehttps://modernaesthetics.com/news/fda-sets-november-pdufa-date-for-daxibotulinumtoxina-from-revance/2472880/FDA has accepted the Biologics License Application (BLA) for DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar (frown) lines, Revance reports. The FDA set an action date of November 25, 2020 under the Prescription Drug User Fee Act (PDUFA) VI program.
- Allergan's New Philanthropic Program Will Benefit Kids with Upper Limb Spasticityhttps://modernaesthetics.com/news/allergans-new-philanthropic-program-will-benefit-kids-with-upper-limb-spasticity/2472879/Allergan is launching the Be The Difference philanthropic program to support children and their families who may benefit from treatment with Botox (onabotulinumtoxinA) for pediatric upper limb spasticity. Botox is approved to treat increased muscle stiffness in children 2 to 17 years of
- SkinMedica's DiamondGlow Hits Doctor's Officeshttps://modernaesthetics.com/news/skinmedicas-diamondglow-hits-doctors-offices/2472875/llergan’s Skinmedica is rolling out DiamondGlow, a non-invasive dermabrasion technology that exfoliates, extracts, and treats the face, eye area, lips and body. Allergan acquired Envy Medical, Inc and its Silkpeel&nbs
- Most Plastic Surgery YouTube and Social Media Videos Are Poor Qualityhttps://modernaesthetics.com/news/most-plastic-surgery-youtube-and-social-media-videos-are-poor-quality/2472874/YouTube and social media videos aren't necessarily the most reliable source of plastic surgery information, concludes a study in the February issue of Plastic and Reconstructive Surgery. Despite this, a recent American So
- From Baby Botox to Daddy Do-Overs, the Aesthetic Society Predicts the Hottest Trends for 2020https://modernaesthetics.com/news/from-baby-botox-to-daddy-do-overs-the-aesthetic-society-predicts-the-hottest-trends-for-2020/2472873/The Aesthetic Society predicts that 2020 will usher in the return of the facelift and the rise of the daddy do-over, i.e the male counterpart to t
- Alma’s Opus Plasma Debuts in North Americahttps://modernaesthetics.com/news/almas-opus-plasma-debuts-in-north-america/2472871/Alma, Inc. is launching Opus in North America. Opus is a new platform featuring the company's proprietary high-frequency unipolar radio-frequency technology, Opus Plasma. Opus Plasma is the first fractional plasma technology to enter the f
- Crown Aesthetics Adds ProGen PRP Advantage to Portfoliohttps://modernaesthetics.com/news/crown-aesthetics-adds-progen-prp-advantage-to-portfolio/2472870/ProGen PRP Advantage, an easy-to-use, single-spin system that features 15ml and 30ml tubes, yielding 7-15ml of 2x concentration PRP, is now available from Crown Aesthetics, a division of Crown Laboratories, Inc. With the launch of
- Crown Laboratories Restructures after Acquisitionshttps://modernaesthetics.com/news/crown-laboratories-restructures-after-acquisitions/2472866/Crown Laboratories has restructured its commercial operations business units as it continues to elevate its new “Skin Science for Life” commitment. For the past two years, Crown says it has been dedicated to transforming its Northeast Tennessee operations into a global skinc
- Revance Enters Exclusive Distribution Deal with Teoxane SA for Dermal Fillershttps://modernaesthetics.com/news/revance-enters-exclusive-distribution-deal-with-teoxane-sa-for-dermal-fillers/2472863/With the signing of a new distribution agreement, Revance Therapeutics, Inc. is now the exclusive US commercialization partner of Teoxane SA for its dermal filler products. Revance has immediate and exclusive rights to commercialize Teoxane’s Resilient Hyaluronic Acid® (R